Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Aug 15, 2025, 11:13 AM
Brainstorm Cell Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for BCLI stock have an median target of 30, with a low estimate of 30 and a high estimate of 30. The median target predicts an increase of 4900.00% from the current stock price of 0.60.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 30 | 30 | 30 | 30 |
| Change | 4900.00% | 4900.00% | 4900.00% | 4900.00% |
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Brainstorm Cell Therapeutics Inc. is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Jul 24 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Financial Forecast this Year
Revenue This Year
258M
from 849K
Increased by 30.29K%
Revenue Next Year
426.9M
from 258M
Increased by 65.5%
EPS This Year
-1.6
from 2.19
Increased by 26.9%
EPS Next Year
-0.93
from -1.6
Increased by 41.9%